Skip to content
Search

Latest Stories

Community pharmacy workforce is in fragile condition, says CCA report

Community pharmacy workforce is in a fragile condition and faced a shortfall of 3,000 pharmacists in England over a period of five years, a recent research conducted by the Company Chemists’ Association (CCA) has revealed.

It noted that over the last five years, the net growth of community pharmacists in England a year stood at 733. This is much lower than the required average growth of 1,025, based on data reported by the Health Education England workforce survey from 2021.


Acknowledging the discrepancies in the data calculation, the paper published by the association has used “the best available data” to highlight recent changes to the community pharmacy workforce in England.

The report noted that despite an increase in the number of pharmacists, many contractors reported an increase in pharmacist vacancies. They also reported a significant increase in locum hourly pay rates, indicating demand exceeds supply.

The CCA report highlighted other factors for workforce shortages, such as:

Changing work patterns: The report cited increased part time working, reduced working hours and portfolio working as main reasons for this condition.

The 2021 HEE workforce survey reported that average number of pharmacists by headcount per store increased to 2.43 from 1.97 in 2017, meaning on average each store had 0.46 more pharmacists. As per the CCA’s estimate, around 1,025 more pharmacists are required each year to retain equilibrium.

High vacancy rates among pharmacy support staff: The HEE 2021 workforce survey found a considerable growth in vacancies rate among support staff, which would have an impact on the workload of pharmacists.

Recruitment in Primary Care Networks (PCNs): The CCA noted that in December 2021, NHS E/I confirmed recruiting around 3,500 pharmacists into PCNs with an estimated 2,100 recruits from community pharmacy. Assuming 62 per cent of pharmacists work in community pharmacy, the CCA report estimated that around 2,385 came from the community setting.

It noted that other factors that affect the community pharmacy workforce include the growing number of non-practicing pharmacists, impact of broader portfolio working, population growth, cross border working, etc.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less